OBJECTIVES: To determine infection patterns of sexually transmitted infections that facilitate HIV transmission among HIV-discordant couples. METHODS: 112 initial respondents were recruited in an impoverished neighbourhood of Brooklyn, New York. Their sexual (and injection) partners were recruited in up to four additional network sampling waves for a final sample of 465 persons aged 18 years or older. After separate informed consent had been obtained, blood and urine were collected and tested for HIV, type-specific antibodies to herpes simplex virus (HSV-2), syphilis, chlamydia and gonorrhoea. RESULTS: Of 30 HIV-discordant partnerships, five were same-sex male partnerships and 25 were opposite-sex partnerships. No subjects tested positive for syphilis or gonorrhoea. Two couples were chlamydia-discordant. For HSV-2, 16 couples were double-positive, eight discordant, four double-negative, and two comprised a HSV-2-negative with a partner with missing herpes data. CONCLUSIONS: HSV-2 was present in 83% of the HIV-discordant couples, chlamydia in 7%, and syphilis and gonorrhoea in none. HSV-2 is probably more important for HIV transmission than bacterial sexually transmitted diseases because it is more widespread. Even given the limited generalisability of this community-based sample, there seems to be an important HIV-prevention role for herpes detection and prevention activities in places where HIV-infected people are likely to be encountered, including sexually transmitted disease clinics, HIV counselling and testing programmes, prisons, needle exchanges, and drug abuse treatment programmes. The effects of HSV-suppressive therapy in highly impacted groups should also be investigated.
OBJECTIVES: To determine infection patterns of sexually transmitted infections that facilitate HIV transmission among HIV-discordant couples. METHODS: 112 initial respondents were recruited in an impoverished neighbourhood of Brooklyn, New York. Their sexual (and injection) partners were recruited in up to four additional network sampling waves for a final sample of 465 persons aged 18 years or older. After separate informed consent had been obtained, blood and urine were collected and tested for HIV, type-specific antibodies to herpes simplex virus (HSV-2), syphilis, chlamydia and gonorrhoea. RESULTS: Of 30 HIV-discordant partnerships, five were same-sex male partnerships and 25 were opposite-sex partnerships. No subjects tested positive for syphilis or gonorrhoea. Two couples were chlamydia-discordant. For HSV-2, 16 couples were double-positive, eight discordant, four double-negative, and two comprised a HSV-2-negative with a partner with missing herpes data. CONCLUSIONS:HSV-2 was present in 83% of the HIV-discordant couples, chlamydia in 7%, and syphilis and gonorrhoea in none. HSV-2 is probably more important for HIV transmission than bacterial sexually transmitted diseases because it is more widespread. Even given the limited generalisability of this community-based sample, there seems to be an important HIV-prevention role for herpes detection and prevention activities in places where HIV-infectedpeople are likely to be encountered, including sexually transmitted disease clinics, HIV counselling and testing programmes, prisons, needle exchanges, and drug abuse treatment programmes. The effects of HSV-suppressive therapy in highly impacted groups should also be investigated.
Authors: Samuel R Friedman; Leslie Williams; April M Young; Jennifer Teubl; Dimitrios Paraskevis; Evangelia Kostaki; Carl Latkin; Danielle German; Pedro Mateu-Gelabert; Honoria Guarino; Tetyana I Vasylyeva; Britt Skaathun; John Schneider; Ania Korobchuk; Pavlo Smyrnov; Georgios Nikolopoulos Journal: Curr HIV/AIDS Rep Date: 2018-06 Impact factor: 5.071
Authors: Maria R Khan; Matthew W Epperson; Pedro Mateu-Gelabert; Melissa Bolyard; Milagros Sandoval; Samuel R Friedman Journal: Am J Public Health Date: 2011-01-13 Impact factor: 9.308
Authors: Gargi Dasgupta; Aziz A Chentoufi; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed Journal: Expert Rev Vaccines Date: 2009-08 Impact factor: 5.217
Authors: Maria R Khan; Melissa Bolyard; Milagros Sandoval; Pedro Mateu-Gelabert; Beatrice Krauss; Sevgi O Aral; Samuel R Friedman Journal: J Acquir Immune Defic Syndr Date: 2009-08-01 Impact factor: 3.731